# Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach

> **NCT05420727** · PHASE1 · COMPLETED · sponsor: **John O. Prior** · enrollment: 14 (actual)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Ga-68-PSMA-11 PET/CT
- **DRUG:** Lu-177-ITG-PSMA-1

## Key facts

- **NCT ID:** NCT05420727
- **Lead sponsor:** John O. Prior
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-08
- **Primary completion:** 2024-04-09
- **Final completion:** 2024-04-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05420727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05420727, "Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05420727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*